Find
27 Feb 2025

Eurex

Equity and Equity Index Derivatives; Introduction of Equity Options, Single Stock Futures and Single Stock Dividend Futures; Cancellation of admission to trading for Equity and Equity Index Derivatives

Eurex Circular 016/25 Equity and Equity Index Derivatives; Introduction of Equity Options, Single Stock Futures and Single Stock Dividend Futures; Cancellation of admission to trading for Equity and Equity Index Derivatives

1. Introduction
 

The Management Board of Eurex Deutschland took the following decisions with effect from 10 March 2025:

  • Introduction of 13 Single Stock Futures pursuant to Annex A to the Contract Specifications for Futures Contracts and Options Contracts at Eurex Deutschland (hereafter referred to as: Contract Specifications) (Attachment 3),
  • Introduction of 10 Equity Options pursuant to Annex B to the Contract Specifications (Attachment 3),
  • Introduction of one Single Stock Dividend Future pursuant to Annex D to the Contract Specifications (Attachment 3),
  • Cancellation of admission to trading for 39 Equity Index derivatives, 9 Single Stock Options, 16 Single Stock Futures and 1 Future on Bitwise Physical Bitcoin ETP pursuant to Attachments 2 and 3.
  • Amendment of the contract expiry cycle for Equity Options on Prosus N.V. (Product ID: PRX) and on Siemens Energy (Product ID: ENR) pursuant to Attachment 3,
  • Further changes to the Contract Specifications pursuant to Attachments 2 and 3.


The Executive Board of Eurex Frankfurt AG took the following decision with effect from 10 March 2025:

  • Amendment of the existing Liquidity Provider Programs "Equity 01 - Equity Options and Selected Equity Index Options", "Equity 02 - Single Stock Futures", "Equity 03 - Single Stock Dividend Futures", “Equity Index 01 - Futures on MSCI Indices”, “Equity Index 02 - Options on MSCI Indices”, and “Equity Index 62 - Futures on STOXX Axioma Factor Indices” with regard to the new products admitted to trading and to the products to be cancelled of admission to trading.


The Executive Board of Eurex Frankfurt AG took the following decision with effect from 1 April 2025:

  • Amendment of the existing Liquidity Provider Program “Equity Index 41 - Futures on STX and DAX ESG Indices” with regard to the products to be cancelled of admission to trading and changes to the Liquidity Provider Program. 

To implement the above decisions of Eurex Deutschland, the Contract Specifications will be amended with effect from 10 March 2025, as outlined in Attachment 2 and 3.
 
This circular contains all information on the introduction of the new products and the updated sections of the relevant Rules and Regulations of Eurex Deutschland.
 
Production start: 10 March 2025
  

2. Required action 

There is no action required for participation.
  

3. Details 
 
A.  Product overview

 

Please refer to Attachment 1 for the products.
 

B.  Contract specifications and product parameters
 

For the detailed contract specifications, please see Attachment 2 and 3.
 

The full version of the updated Contract Specifications will be published on the Eurex website www.eurex.com as of start of trading under:
 

Rules & Regs > Eurex Rules & Regulations > 03. Contract Specifications
 

C.  Admission to the Eurex T7 Entry Services (TES)

The new products will be admitted to the Eurex T7 Entry Services (TES). You can find the minimum block trade sizes on product level in the Contract Specifications in Attachment 2.

An overview of the Eurex T7 Entry Services available for the products as well as detailed information on a single product basis with regard to availability, possibility of utilization and minimum entry size for the various Eurex T7 Entry Services is available on the Eurex website under the link:
 

Data > Trading files > T7 Entry Service parameters
 

D.  Risk parameters

As of start of trading, risk parameters of the new products will be published on the Eurex website under the link:

Data > Clearing files > Risk parameters and initial margins

and on the Eurex Clearing website www.eurex.com/ec-en/ under the following path:

Services > Risk parameters

You will also find an updated list with details regarding Prisma-eligible Eurex products under this path.
 

E.  Excessive System Usage Fee and Order to Trade Ratio 
  

The Excessive System Usage Fee and the Order to Trade Ratio for the new products are determined in line with the existing products. For detailed information, please refer to the Eurex website under the following links:
 
Rules & Regs > Regulations > Excessive System Usage Fee

Rules & Regs > Regulations > Order-to-Trade Ratio


F. Mistrade parameters and position limits

Mistrade ranges and position limits for the new products will be published as of start of trading on the Eurex website under the link:

Markets > Product Overview
 

G. Transaction fees
 
For the transaction fees for the new products, please refer to the Price List of Eurex Clearing AG on the Eurex Clearing website www.eurex.com/ec-en/ under the link:

Rules & Regs > Eurex Clearing Rules & Regulations > 3. Price List
 

H. Vendor codes

At start of trading, vendor codes for the new products will be published on the Eurex website under the link:

Markets > Product Overview > Vendor Codes


I. Liquidity Provisioning

Please refer to the attached Product Specific Supplements (Attachment 4 - 10) for details. An overview of Market-Making and Liquidity Provisioning at Eurex can be found on the Eurex website under the following link:

Trade > Market-Making and Liquidity provisioning


J.    Products to be cancelled of admission to trading
 
Please refer to Attachment 1 for the products.


Attachments:

  • 1 – Product overview
  • 2 – Updated sections of the Contract Specifications for Futures Contracts and Options Contracts
    at Eurex Deutschland
  • 3 – Updated Annexes to the Contract Specifications for Futures Contracts and Options Contracts at Eurex Deutschland
  • 4 – Product Specific Supplement (PSS) for Equity Options and Selected Equity Index Options – Equity 01
  • 5 – Product Specific Supplement (PSS) for Single Stock Futures – Equity 02
  • 6 – Product Specific Supplement (PSS) for Single Stock Dividend Futures – Equity 03
  • 7 – Product Specific Supplement (PSS) for Equity Index 01 - Futures on MSCI Indices 
  • 8 – Product Specific Supplement (PSS) for Equity Index 02 - Options on MSCI Indices
  • 9 – Product Specific Supplement (PSS) for Equity Index 41 - Futures on STX and DAX ESG Indices
  • 10 – Product Specific Supplement (PSS) for Equity Index 62 - Futures on STOXX Axioma Factor Indices

Further information
 

Recipients: 

All Trading Participants of Eurex Deutschland and Vendors 

Target groups: 

Front Office/Trading, Middle + Backoffice, IT/System Administration, Auditing/Security Coordination 

Contact: 

client.services@eurex.com

Web: 

www.eurex.com 

Authorized by: 

Randolf Roth


Market Status

XEUR

The market status window is an indication regarding the current technical availability of the trading system. It indicates whether news board messages regarding current technical issues of the trading system have been published or will be published shortly.

Please find further information about incident handling in the Emergency Playbook published on the Eurex webpage under Support --> Emergencies and safeguards. Detailed information about incident communication, market re-opening procedures and best practices for order and trade reconciliation can be found in the chapters 4.2, 4.3 and 4.5, respectively. Concrete information for the respective incident will be published during the incident via newsboard message. 

We strongly recommend not to take any decisions based on the indications in the market status window but to always check the production news board for comprehensive information on an incident.

An instant update of the Market Status requires an enabled up-to date Java™ version within the browser.